Dr. Donald Hannoun

Dr. Donald Hannoun
Donald Hannoun, M.D., is a surgeon and assistant clinical professor practicing urology and urologic oncology at City of Hope Palmdale and Santa Clarita locations. Dr. Hannoun attended medical school and completed both an internship and residency at Keck School of Medicine of USC, where he was elected to membership in the Alpha Omega Alpha Honorary Medical Society. He is the recipient of multiple awards and honors including the Dean’s Recognition Award from Keck School of Medicine, and was recognized as Intern of the Year by its Department of General Surgery. In addition, he was awarded Resident Teacher of the Year from Keck School of Medicine’s Department of Urology in 2009. Dr. Hannoun is an active member in several professional organizations including the American Urological Association and the Los Angeles Urological Society. He has presented several abstracts for the Proceedings of the Western Section of the American Urological Association and has written several articles, abstracts and book chapters. Dr. Hannoun is a highly competent urologic surgeon, who brings his warmth and caring to the bedside, as well as his surgical skills.
Medical School:

Keck School of Medicine, University of Southern California


University of Southern California


Minimally Invasive Urology, Cedars-Sinai Medical Center


University of California, Santa Barbara

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only